"Designing Growth Strategies is in our DNA"
There is a gradual rise in the number of surgeries performed worldwide. Effective bleeding management during the surgeries in order to achieve haemostasis is one of the key determinants of positive outcomes. Difficulties in achieving haemostats are associated with excessive wound bleeding and requirement of blood transfusion especially in the case of anticoagulated patients.
The use of Biodegradable Haemostat increases haemostasis and also provides a wide range of benefits. The benefits of using biodegradable haemostat are reduced operative times, decrease the need for blood transfusion, better visualization of the surgical site and others. There are various existing and under research biodegradable agents which are used to establish haemostats. For example, LYDEX, a biomaterial made from dextran to be used for haemostasis in surgical procedures is under research by BMG Incorporated, a company focussed on developing biomaterial products.
To gain extensive insights into the market, Request for Customization
Increase in number of surgeries and rising concern for the prevention of surgical site or wounds from bleeding and infection are the primary reasons responsible for the growth in the global biodegradable hemostat market. In addition, the various potential advantages of using haemostat agents including the decreased requirement of transfusion, reduced wound healing time, reduced operative time and others are expected to further fuel the global biodegradable haemostat market during the forecast duration.
However, the prominent use of sealants and adhesives to achieve haemostat as an alternative to biodegradable haemostat is a factor that is likely to hamper the growth in global biodegradable haemostat market.
Some of the major companies that are present in the global biodegradable haemostat market are Pfizer Inc., GELITA MEDICAL, Johnson & Johnson Services Inc., C. R. Bard Inc., Bristol-Myers Squibb Company, Stryker, Baxter, CryoLife Inc., Integra LifeSciences, and other players.
By Product Type
· Thrombin-Based Hemostat
· Collagen Based Hemostat
· Gelatin-Based Hemostat
· Oxidized Regenerated Based Hemostat
By End User
· Speciality Clinics
· Ambulatory Surgical Centers
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Among the end user, the hospital segment is estimated to have a greater market share in the global biodegradable hemostat market in the projected years, owing to the number of surgeries performed in the hospitals, usage in larger volumes and government guidelines for bleeding management.
The global biodegradable hemostat market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In North America, the biodegradable haemostat market is anticipated to register a fast growth in the forecast years due to the increased number of surgeries performed and active government interventions to avoid wound bleeding during surgeries. According to the Healthcare Cost and Utilization Project, in 2014, in the U.S., 17.2 million hospital visits (ambulatory or inpatient) included invasive, therapeutic surgeries, which is expected to boost the biodegradable haemostat market in North America. The biodegradable haemostat market in Europe and Asia Pacific is projected to expand by the end of 2025 owing to the rise in number of hospitals and improving health investments.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry